Arihant Superstructures Q1FY27: consolidated PAT down 39% YoY as margins compress

Arihant Superstructures' consolidated revenue for Q1 FY27 rose 8.8% YoY to ₹131.59 Cr (₹120.96 Cr in Q1 FY26) but fell 27.2% QoQ from ₹180.80 Cr in Q4 FY26 — real estate revenue recognition is lumpy and Q4 is typically the seasonally heaviest quarter, so the sequential drop is largely a base effect rather than a demand signal. Consolidated PAT fell 38.5% YoY to ₹9.78 Cr (₹15.91 Cr a year ago), even though it declined only 17.9% QoQ from ₹11.91 Cr — profit growth trailed revenue growth on a YoY basis, the primary read for this quarter, and there were no exceptional items on either side to explain the gap, so the decline is on a like-for-like operating basis. EPS came in at ₹1.39 versus ₹2.21 a year ago and ₹1.68 last quarter. No analyst consensus or brokerage preview for this quarter could be located, so the print's standing versus Street is unknown.

The YoY profit decline traces to margin compression, not overheads or leverage. OPM (EBITDA/revenue) nearly halved to 20.94% from 30.50% in Q1 FY26, and NPM fell to 7.35% from 12.94%. The squeeze sits on the cost-of-construction line: construction & land costs, net of inventory movements, rose to ~62% of revenue from ~53% a year ago — a project-mix effect typical of real estate accounting, where margin on individual projects recognized in a quarter varies. Employee costs (6.4% of revenue) and other expenses (10.7%) held roughly flat as a share of revenue, and finance costs actually eased to 11.8% of revenue from 14.1% YoY. Sequentially, margins improved (OPM 16.72% in Q4 FY26 to 20.94% now), so the quarter looks better QoQ even as revenue normalized off a seasonally high base.

The stock went into the print at ₹262, down 2.1% over the past month of trading.

Management's FY27 guidance from the Q4 FY26 concall (May 18, 2026) called for revenue to scale toward ~₹700 Cr for the full year (25-30% CAGR) with EBITDA margin improving to 25-27%. Q1's ₹131.59 Cr revenue and 20.94% OPM both trail that pace and band — the guidance implies roughly ₹175 Cr/quarter on average — though a single quarter is not conclusive given the sector's lumpy, possession-linked revenue recognition and typically back-loaded quarters. No management press release accompanying this filing was available to check management's own framing. Corporately, the same board meeting fixed the AGM for September 24, 2026 and a dividend record date of September 11, 2026; other developments this quarter were the June 26 insider-trading window closure, the mid-May appointments of Bhavik Chhajer and Parth Chhajer as Joint MDs, and a July 21 independent director appointment (Dr. Raghuveer Singh Rajpurohit) — none bearing directly on the operating numbers.